Science Explorer Back to mapMap
Discussion
Researcher · Toyama College · Japan

Junichi Mitsuyama

Junichi Mitsuyama publishes mostly in Epidemiology, Pharmacology and Infectious Diseases, on topics such as Antibiotics Pharmacokinetics and Efficacy, Pneumonia and Respiratory Infections and Antibiotic Resistance in Bacteria.

OpenAlex
World rank
#3,425,440
of 7,710,434 ranked researchers
Rank in Japan
#82,868
of 383,136
Works
61
Citations
1.3k
Citations per work
21.8
h-index
20
i10-index 27Top 23% in Epidemiology
Junichi Mitsuyama

What does Junichi Mitsuyama research?

Junichi Mitsuyama's work is mostly in Medicine (53%), Biochemistry, Genetics and Molecular Biology (20%), Immunology and Microbiology (8%).

Health Sciences: 32 works · 52.9% of their workMedicine: 32 works · 52.9% of their workEpidemiology: 16 works · 25.9% of their workInfectious Diseases: 8 works · 13.5% of their workPharmacology: 8 works · 13.5% of their workLife Sciences: 17 works · 27.6% of their workBiochemistry, Genetics and Molecular Biology: 12 works · 20.0% of their workMolecular Medicine: 7 works · 11.8% of their workMolecular Biology: 5 works · 8.2% of their workImmunology and Microbiology: 5 works · 7.6% of their workMicrobiology: 5 works · 7.6% of their workEverything else: 12 works · 19.5% of their workTHEIR WORKJunichi Mitsuyama61works
Life Sciences28%Health Sciences53%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3252.9%
    1. Biochemistry, Genetics and Molecular Biology1220.0%
    2. Immunology and Microbiology57.6%
  3. Everything else1219.5%
  1. 1Epidemiology26% of their works
  2. 2Pharmacology14% of their works
  3. 3Infectious Diseases14% of their works
  4. 4Molecular Medicine12% of their works
  5. 5Molecular Biology8% of their works
  6. 6Microbiology8% of their works

Research topics

Which keywords describe Junichi Mitsuyama's research?

The keywords of their largest research topics: Epidemiology, Antimicrobial Resistance, Antibiotic Pharmacokinetics, Antifungal Therapy, Critically Ill Patients, Community-Acquired Pneumonia, Pneumococcal Conjugate Vaccine and Antibiotic Resistance.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Epidemiology605 topics
  2. Antimicrobial Resistance513 topics
  3. Antibiotic Pharmacokinetics221 topic
  4. Antifungal Therapy222 topics
  5. Critically Ill Patients221 topic
  6. Community-Acquired Pneumonia211 topic
  7. Pneumococcal Conjugate Vaccine211 topic
  8. Antibiotic Resistance201 topic
  9. Clinical Management202 topics
  10. Multidrug-Resistant Bacteria201 topic
  11. Virulence Factors162 topics
  12. Candidiasis141 topic
  13. Invasive Fungal Infections141 topic
  14. Bacterial Meningitis121 topic
  15. Neisseria meningitidis121 topic
  16. Cryptococcal Disease81 topic
  17. Histoplasmosis81 topic
  18. MRSA81 topic
  19. Staphylococcus aureus81 topic
  20. Human Metapneumovirus51 topic
  21. Respiratory Syncytial Virus51 topic

Where does Junichi Mitsuyama work?

Junichi Mitsuyama's main affiliation in the publication record is Toyama College, Japan.

How many publications and citations does Junichi Mitsuyama have?

OpenAlex counts 61 works and 1,332 citations for Junichi Mitsuyama, an h-index of 20, ranking #3,425,440 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Junichi Mitsuyama. Posts are plain text and can be reported.